Human papillomavirus DNA testing for cervical cancer screening in low- resource settings

Journal of the National Cancer Institute

Volumn 92, Issue 10, 2000, Pages 818-825

  Kuhn, Louise ^a   Denny, Lynette ^e   Pollack, Amy ^b   Lorincz, Attila ^c   Richart, Ralph M ^e   Wright, Thomas C ^d  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b AVSC International   (United States)

^c Digene Corporation   (United States)

^d Coll Phys Surgs Columbia U ^*  (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

EID: 0034679106     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.10.818     Document Type: Article

References (24)

1. International Agency for Research on Cancer (IARC). Human papillomaviruses. Monogr Eval Carcinog Risks Hum. Lyon (France): IARC; 1995.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9
3. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
4. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
5. Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TJ, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomor-phologically normal cervical smears. Int J Cancer 1996;68:766-9.
6. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 1996;88:261-8.
7. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-9.
8. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
9. Evander M., Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E, et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 1995;171:1026-30.
10. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 1993;82:578-85.
11. Ferenczy A, Franco E., Arseneau J, Wright TC, Richart RM. Diagnostic-performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am J Obstet Gynecol 1996;175:651-6.
12. Wright TC Jr., Lorincz A, Ferris DG, Richart RM, Ferenczy A, Mielzynska I, et al. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 1998; 178:962-6.
13. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
14. Program for Appropriate Technology in Health (PATH). Planning appropriate cervical cancer control programs. Seattle (WA): PATH; 1997.
15. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994;170:1077-85.
16. Reid R. Colposcopy of cervical preinvasive neoplasia. In: Singer A, editor. Premalignant lesions of the lower genital tract. New York (NY): Elsevier; 1990.
17. Wright TC, Ferenczy AF, Kurman R. Precancerous lesions of the cervix. In: Kurman R, editor. Blaustein's pathology of the female genital tract. New York (NY): Springer-Verlag; 1994. p. 229-78.
18. Kleinbaum D, Kupper L, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont (MA): Lifetime Learning Publications; 1982.
19. Schatzkin A, Connor RJ, Taylor PR, Bunnag B. Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer. Am J Epidemiol 1987;125:672-8.
20. Chock C, Irwig L, Berry G, Glasziou P. Comparing dichotomous screening tests when individuals negative on both tests are not verified. J Clin Epidemiol 1997;50:1211-7.
21. Metz CE, Herman BA, Shen JH. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. Stat Med 1998;17:1033-53.
22. Meisels A, Morin C. Cytopathology of the uterine cervix. Chicago (IL): American Society of Clinical Pathologists; 1991.
23. Mitchell MF, Cantor SB, Ramanujam N, Tortolero-Luna G, Richards-Kortum R. Fluorescence spectroscopy for diagnosis of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1999;93:462-70.
24. Fahey MT, Irwig LM, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-9.